Home > Balance Sheet > MANKIND PHARMA

MANKIND PHARMA
Capital Work in Progress

    Back to Balance Sheet
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
Best 1M Momentum Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Capital Work in Progress History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Capital Work in Progress ₹306 Cr₹207 Cr₹493 Cr₹670 Cr₹372 Cr

What is the latest Capital Work in Progress ratio of MANKIND PHARMA ?

The latest Capital Work in Progress ratio of MANKIND PHARMA is ₹306 Cr based on Mar2025 Consolidated results.
Year Capital Work in Progress
Mar2025₹306 Cr
Mar2024₹207 Cr
Mar2023₹493 Cr
Mar2022₹670 Cr
Mar2021₹372 Cr

How is Capital Work in Progress of MANKIND PHARMA Trending?

Years Capital Work in Progress % Change
Mar2025 ₹306 Cr
47.82
Mar2024 ₹207 Cr
-58.01
Mar2023 ₹493 Cr
-26.38
Mar2022 ₹670 Cr
80.26
Mar2021 ₹372 Cr -

Compare Capital Work in Progress of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹109,846.1 Cr 3% 6.2% 7.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹397,342.0 Cr 3.4% 1.3% -11.6% Stock Analytics
DIVIS LABORATORIES ₹164,555.0 Cr 2.4% 3.2% 11.9% Stock Analytics
CIPLA ₹127,259.0 Cr 1.8% 1.9% -5.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,898.0 Cr 2.8% -0.9% 3.3% Stock Analytics
DR REDDYS LABORATORIES ₹110,394.0 Cr 1.7% 6.2% -0.3% Stock Analytics


MANKIND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

3%

6.2%

7.5%

SENSEX

0.9%

1.2%

-0.4%


You may also like the below Video Courses